Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1213-1224

  Liu, Jian ^a   Zhang, Xiaoling ^a   Liu, Aiguo ^a   Liu, Shuangyou ^a   Zhang, Liuqing ^a   Wu, Bei ^a   Hu, Qun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Berberine; Leukemia; XIAP

Indexed keywords

ACTIN; BERBERINE; DOXORUBICIN; PROTEASOME; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EXPOSURE; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BERBERINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84890628296     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354520     Document Type: Article

References (49)

1. Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-1548.
2. Pui CH, Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178.
3. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M: Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999;94:1209-1217.
4. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
5. Holcik M, Korneluk RG: Xiap, the guardian angel. Nat Rev Mol Cell Biol 2001;2:550-556.
6. Suzuki Y, Nakabayashi Y, Takahashi R: Ubiquitin-protein ligase activity of x-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in fasinduced cell death. Proc Natl Acad Sci U S A 2001;98:8662-8667.
7. Dai Y, Rahmani M, Dent P, Grant S: Blockade of histone deacetylase inhibitor-induced rela/p65 acetylation and nf-kappab activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, xiap downregulation, and c-jun n-terminal kinase 1 activation. Mol Cell Biol 2005;25:5429-5444.
8. Gu L, Zhu N, Zhang H, Durden DL, Feng Y, Zhou M: Regulation of xiap translation and induction by mdm2 following irradiation. Cancer Cell 2009;15:363-375.
9. Galban S, Duckett CS: Xiap as a ubiquitin ligase in cellular signaling. Cell Death Differ 2010;17:54-60.
10. Du C, Fang M, Li Y, Li L, Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating iap inhibition. Cell 2000;102:33-42.
11. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG: Identification of xaf1 as an antagonist of xiap anti-caspase activity. Nat Cell Biol 2001;3:128-133.
12. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R: A serine protease, htra2, is released from the mitochondria and interacts with xiap, inducing cell death. Mol Cell 2001;8:613-621.
13. Ye M, Fu S, Pi R, He F: Neuropharmacological and pharmacokinetic properties of berberine: A review of recent research. J Pharm Pharmacol 2009;61:831-837.
14. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma snu-5 cell line. World J Gastroenterol 2006;12:21-28.
15. Mantena SK, Sharma SD, Katiyar SK: Berberine, a natural product, induces g1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006;5:296-308.
16. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST: Down-regulation of cyclin b1 and up-regulation of wee1 by berberine promotes entry of leukemia cells into the g2/m-phase of the cell cycle. Anticancer Res 2006;26:1097-1104.
17. Zhang X, Gu L, Li J, Shah N, He J, Yang L, Hu Q, Zhou M: Degradation of mdm2 by the interaction between berberine and daxx leads to potent apoptosis in mdm2-overexpressing cancer cells. Cancer Res 2010;70:9895-9904.
18. Zhou M, Yeager AM, Smith SD, Findley HW: Overexpression of the mdm2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 1995;85:1608-1614.
19. Findley HW, Gu L, Yeager AM, Zhou M: Expression and regulation of bcl-2, bcl-xl, and bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997;89:2986-2993.
20. Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW: DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 2002;303:124-131.
21. Mayo LD, Donner DB: A phosphatidylinositol 3-kinase/akt pathway promotes translocation of mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A 2001;98:11598-11603.
22. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD: Ubiquitin protein ligase activity of iaps and their degradation in proteasomes in response to apoptotic stimuli. Science 2000;288:874-877.
23. Oren M: Decision making by p53: Life, death and cancer. Cell Death Differ 2003;10:431-442.
24. El-Deiry WS: The role of p53 in chemosensitivity and radiosensitivity. Oncogene 2003;22:7486-7495.
25. Hundsdoerfer P, Dietrich I, Schmelz K, Eckert C, Henze G: Xiap expression is post-transcriptionally upregulated in childhood all and is associated with glucocorticoid response in t-cell all. Pediatr Blood Cancer 2010;55:260-266.
26. Chen H, Hao Y, Wang L, Jia D, Ruan Y, Gu J: Sodium arsenite down-regulates the expression of x-linked inhibitor of apoptosis protein via translational and post-translational mechanisms in hepatocellular carcinoma. Biochem Biophys Res Commun 2012;422:721-726.
27. Silvera D, Formenti SC, Schneider RJ: Translational control in cancer. Nat Rev Cancer 2010;10:254-266.
28. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC: Cleavage of human inhibitor of apoptosis protein xiap results in fragments with distinct specificities for caspases. EMBO J 1999;18:5242-5251.
29. Kobayashi S, Yamashita K, Takeoka T, Ohtsuki T, Suzuki Y, Takahashi R, Yamamoto K, Kaufmann SH, Uchiyama T, Sasada M, Takahashi A: Calpain-mediated x-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem 2002;277:33968-33977.
30. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK, Cheng JQ: Akt phosphorylation and stabilization of x-linked inhibitor of apoptosis protein (xiap). J Biol Chem 2004;279:5405-5412.
31. Kuo HP, Chuang TC, Yeh MH, Hsu SC, Way TD, Chen PY, Wang SS, Chang YH, Kao MC, Liu JY: Growth suppression of her2-overexpressing breast cancer cells by berberine via modulation of the her2/pi3k/akt signaling pathway. J Agric Food Chem 2011;59:8216-8224.
32. Kuo HP, Chuang TC, Tsai SC, Tseng HH, Hsu SC, Chen YC, Kuo CL, Kuo YH, Liu JY, Kao MC: Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via akt pathway modulation. J Agric Food Chem 2012;60:9649-9658.
33. Chauhan D, Neri P, Velankar M, Podar K, Hideshima T, Fulciniti M, Tassone P, Raje N, Mitsiades C, Mitsiades N, Richardson P, Zawel L, Tran M, Munshi N, Anderson KC: Targeting mitochondrial factor smac/diablo as therapy for multiple myeloma (mm). Blood 2007;109:1220-1227.
34. Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Bhanot U, Hasel C, Moller P, Gschwend JE, Simmet T, Debatin KM, Fulda S: Small molecule xiap inhibitors enhance trail-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Cancer Res 2009;69:2425-2434.
35. Carter BZ, Mak DH, Schober WD, Koller E, Pinilla C, Vassilev LT, Reed JC, Andreeff M: Simultaneous activation of p53 and inhibition of xiap enhance the activation of apoptosis signaling pathways in aml. Blood 2010;115:306-314.
36. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB: Characterization of xiap-deficient mice. Mol Cell Biol 2001;21:3604-3608.
37. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG: Iap-targeted therapies for cancer. Oncogene 2008;27:6252-6275.
38. Schyschka L, Rudy A, Jeremias I, Barth N, Pettit GR, Vollmar AM: Spongistatin 1: A new chemosensitizing marine compound that degrades xiap. Leukemia 2008;22:1737-1745.
39. Holt SV, Brookes KE, Dive C, Makin GW: Down-regulation of xiap by aeg35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents. Oncol Rep 2011;25:1177-1181.
40. Liu Y, Wu X, Sun Y, Chen F: Silencing of x-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer. J Int Med Res 2011;39:1682-1692.
41. Wang S: Design of small-molecule smac mimetics as iap antagonists. Curr Top Microbiol Immunol 2011;348:89-113.
42. Danson S, Dean E, Dive C, Ranson M: Iaps as a target for anticancer therapy. Curr Cancer Drug Targets 2007;7:785-794.
43. Sun Y, Xun K, Wang Y, Chen X: A systematic review of the anticancer properties of berberine, a natural product from chinese herbs. Anticancer Drugs 2009;20:757-769.
44. Chen CM, Chang HC: Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1995;665:117-123.
45. Kheir MM, Wang Y, Hua L, Hu J, Li L, Lei F, Du L: Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol 2010;48:1105-1110.
46. Huang ZJ, Zeng Y, Lan P, Sun PH, Chen WM: Advances in structural modifications and biological activities of berberine: An active compound in traditional chinese medicine. Mini Rev Med Chem 2011;11:1122-1129.
47. Gui SY, Wu L, Peng DY, Liu QY, Yin BP, Shen JZ: Preparation and evaluation of a microemulsion for oral delivery of berberine. Pharmazie 2008;63:516-519.
48. Zuo F, Nakamura N, Akao T, Hattori M: Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab Dispos 2006;34:2064-2072.
49. Liu YT, Hao HP, Xie HG, Lai L, Wang Q, Liu CX, Wang GJ: Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos 2010;38:1779-1784.